loader image
Sunday, December 21, 2025
79 F
McAllen
- Advertisement -

Higher Blood Caffeine Levels Linked to Lower Obesity & Osteoarthritis Risk

Translate to Spanish or other 102 languages!

New study appears to confirm caffeine’s protective effect against obesity and joint disease. Image for illustration purposes
New study appears to confirm caffeine’s protective effect against obesity and joint disease. Image for illustration purposes
- Advertisement -
  • Researchers estimate that more than 1 billion people globally have obesity. 
  • Obesity can increase a person’s risk for several health problems, including joint conditions, such as osteoarthritis.
  • Scientists from Imperial College London in the United Kingdom and the University of Copenhagen in Denmark have recently found that high levels of caffeine in the blood over a long time, influenced by consumption and genetically controlled metabolism, may help protect the body against both obesity and joint disease.

According to the latest research, more than 1 billion peopleTrusted Source around the world — both adults and children — have obesity

Follow the link below to Medical News today to read the full story:

https://www.medicalnewstoday.com/articles/higher-blood-caffeine-levels-linked-to-lower-obesity-and-osteoarthritis-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-06&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×